![Cambridge Cognition Holdings](https://directorstalk.net/wp-content/uploads/2017/03/cambridge-cognition-holdings.jpg)
Digital brain biomarker start-up Monument Therapeutics appoints Acacia and Arakis founder Julian Gilbert to Board
Monument Therapeutics, a stratified medicine company, has announced the appointment of Dr Julian Gilbert to its Board as a Non-Executive Director. Monument recently raised £2.625 million in seed funding and